| Literature DB >> 24305067 |
Farkaad A Kadir1, Normadiah M Kassim, Mahmood A Abdulla, Wageeh A Yehye.
Abstract
BACKGROUND: Hepatocellular carcinoma is a common type of tumour worldwide with a high mortality rate and with low response to current cytotoxic and chemotherapeutic drugs. The prediction of activity spectra for the substances (PASS) software, which predicted that more than 300 pharmacological effects, biological and biochemical mechanisms based on the structural formula of the substance was efficiently used in this study to reveal new multitalented actions for Vitex negundo (VN) constituents.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24305067 PMCID: PMC4235047 DOI: 10.1186/1472-6882-13-343
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
antioxidant for cell line experimental design
| No oxidant agent (10 μl medium) | 10 μl solvent | |
| 10 μl | 10 μl solvent | |
| 10 μl | VN ethanol extract (10 μl) |
Part of PASS for VN chemical compounds
| | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.813 | 0.003 | 0.699 | 0.004 | 0.786 | 0.003 | 0.717 | 0.007 | 0.741 | 0.009 | 0.737 | 0.012 | |
| 0.765 | 0.004 | 0.671 | 0.004 | 0.765 | 0.003 | 0.744 | 0.006 | 0.706 | 0.011 | 0.754 | 0.011 | |
| 0.798 | 0.004 | 0.749 | 0,004 | 0.849 | 0.002 | 0.741 | 0.006 | 0.778 | 0.007 | 0.886 | 0.005 | |
| 0.711 | 0.005 | 0.644 | 0.004 | 0.751 | 0.003 | 0.658 | 0.009 | 0.734 | 0.009 | 0.855 | 0.005 | |
| 0.952 | 0.002 | 0.874 | 0.003 | 0.973 | 0.001 | 0.912 | 0.002 | 0.812 | 0.005 | 0.817 | 0.007 | |
| 0.304 | 0.062 | 0.788 | 0.003 | 0.518 | 0.009 | 0.983 | 0.001 | 0.679 | 0.012 | 0.445 | 0.005 | |
| 0.415 | 0.031 | 0.598 | 0.005 | 0.698 | 0.004 | 0.986 | 0.001 | 0.611 | 0.006 | 0.554 | 0.014 | |
| 0.920 | 0.002 | 0.798 | 0.003 | 0.956 | 0.001 | 0.924 | 0.002 | 0.749 | 0.008 | 0.715 | 0.013 | |
Pa—probability “to be active”; Pi—probability “to be inactive”.
(1) 5-hydroxy-7,4′dimethoxy flavones, (2) 5-hydroxy-3,6,7,3′,4′-Pentamethoxy flavones, (3) 5, 3′ dihydroxy-7, 8,4′-trimethoxy flavanone, (4) 5,7-dihydroxy-6,4′dimethoxy flavanone, (5) 7,8-dimethyl herbacetin 3-rhamnoside, (6) Agnuside, (7) Negundoside, (8) Vitegnoside.
Figure 1The percentage of scavenging activity of ethanolic extract of VN against DPPH.
Figure 2Ferric reducing antioxidant property (FRAP) of the leave extract of VN. Values are presented as means ± SEM, * P < 0.05 versus BHT.
IC value and percentage inhibition of the DPPH radical scavenging assay
| 2.35 ±0.07 | 13.05 ±0.07 | 48.4 ± 0.01 | 15.1 ±0.14 | |
| 2.58 ± 0.4 | 29.15 ±0.21 | 89.3 ±0.51 | 21.24 ±0.86 | |
| 43.5 0.47 | 44.5 ±0.07 | 89.1 ±1.27 | 48.06 ±1.18 | |
| 64.2 ±0.94 | 66.32 ±0.96 | 89.17 ±1.65 | 82.09 ±1.09 | |
| 79.43 ±1.3 | 82.53 ±1.7 | 89.51 ±1.14 | 90.65 ±1.34 | |
| 13.31 ± 0.18 | 13.8 ± 0.14 | 3.1 ± 0.08 | 12.9 ± 0.12 | |
aSEM: standard error of the mean. bIC50: 50% effective concentration. IC50 is determined by using Masterplex 2010 software (5Parameters logistics).
Figure 3Co-antioxidant effectively recycles antioxidant. AH = antioxidants, α-TOH; CoAH = co-antioxidant.
Effects of H O , VN extract on the antioxidant enzymes and MDA level on H O – induced WRL-68 cell line
| 10.61 ± 0.010 | 27.14 ± 0.30 | 17.00 ± 1.019 | |
| 10.00 ± 0.065 | 10.98 ± 0.18a | 46.94 ± 1.730a | |
| 10.37 ± 0.150 | 22.05 ± 0.19b | 23.17 ± 2.165b |
Values are presented as means ± S.E.M, aP < 0.05 versus normal control group, bP < 0.05 versus H2O2 group.
Comparison of IC values for HepG2 and WRL 68 cells obtained from MTT assay following exposure to VN extract for 24,48 and 72 hours
| WRL 68 | VN | 24 | >100 a |
| 48 | >100 a | ||
| 72 | >100 a | ||
| Hep G2 | VN | 24 | 66.46 ± 2.8 |
| 48 | 57.36 ± 1.3 | ||
| 72 | 65.12 ± 1.8 |
The IC50 value is defined as the concentration of sample necessary to inhibit 50% of the cells. aValue not reach 50% inhibition. IC50 is determined by using Masterplex 2010 software (5Parameters logistics).
Figure 4Effect of VN treatment on HepG2 cell lines viability.
Figure 5Effect of VN treatment on WRL68 cell lines viability.
Figure 6Photomicrographs showing the comparison of the morphology of HepG2 cells. Before and after treatment with VN extract (A) untreated cells (normal control). (B) VN treated cells, (magnification × 10).
Figure 7Effect of VN and CS on morphology of HepG2 cells. (A) Untreated controlled cells. (B) VN treated cells, full white head arrows: apoptotic cells and dashed dotted arrow indicated cell with fragmented nuclei. AO/EB staining, fluorescence microscope, Bar = 50 μm.
Figure 8Effect of VN treatment in WRL68 and HepG2 cell lines on LDH release.
Figure 9Caspase-3 activity of HepG2 cells treated with VN.